IRON seen with multiple late-stage catalysts across hematology programs
TradingView reports upcoming late-stage catalysts for IRON, including phase III data for a bitopertin program in porphyria; Selcodebart data in myelofibrosis; and first patient data for DISC-3405 in polycythemia vera.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.